These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19727125)

  • 41. Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia.
    Mezzano D; Pais EO; Aranda E; Panes O; Downey P; Ortiz M; Tagle R; González F; Quiroga T; Caceres MS; Leighton F; Pereira J
    Kidney Int; 2001 Nov; 60(5):1844-50. PubMed ID: 11703602
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
    Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
    Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inflammation and oxidative stress in ESRD--the role of myeloperoxidase.
    Maruyama Y; Lindholm B; Stenvinkel P
    J Nephrol; 2004; 17 Suppl 8():S72-6. PubMed ID: 15599890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Caloric restriction improves endothelial dysfunction during vascular aging: Effects on nitric oxide synthase isoforms and oxidative stress in rat aorta.
    Zanetti M; Gortan Cappellari G; Burekovic I; Barazzoni R; Stebel M; Guarnieri G
    Exp Gerontol; 2010 Nov; 45(11):848-55. PubMed ID: 20637278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease.
    Fujii H; Nakai K; Fukagawa M
    Ther Apher Dial; 2011 Apr; 15(2):125-8. PubMed ID: 21426501
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiovascular disease and chronic kidney disease: insights and an update.
    Best PJ; Reddan DN; Berger PB; Szczech LA; McCullough PA; Califf RM
    Am Heart J; 2004 Aug; 148(2):230-42. PubMed ID: 15308992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiovascular complications of pediatric chronic kidney disease.
    Mitsnefes MM
    Pediatr Nephrol; 2008 Jan; 23(1):27-39. PubMed ID: 17120060
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Vascular endothelial dysfunction, oxidative stress--a new topic within the referral section of Orvosi Hetilap].
    Fischer T
    Orv Hetil; 2008 Jul; 149(28):1323-7. PubMed ID: 18617460
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease.
    Tatematsu S; Wakino S; Kanda T; Homma K; Yoshioka K; Hasegawa K; Sugano N; Kimoto M; Saruta T; Hayashi K
    J Am Soc Nephrol; 2007 Mar; 18(3):741-9. PubMed ID: 17267746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biomarkers determining cardiovascular risk in patients with kidney disease.
    Siasos G; Tousoulis D; Michalea S; Oikonomou E; Kolia C; Kioufis S; Synetos A; Vlasis K; Papavassiliou AG; Stefanadis C
    Curr Med Chem; 2012; 19(16):2555-71. PubMed ID: 22489717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessing Microvascular Function in Humans from a Chronic Disease Perspective.
    Houben AJHM; Martens RJH; Stehouwer CDA
    J Am Soc Nephrol; 2017 Dec; 28(12):3461-3472. PubMed ID: 28904002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolic derangements seen in chronic kidney disease and end-stage renal disease patients.
    Gupta D; Misra M
    Contrib Nephrol; 2011; 171():113-119. PubMed ID: 21625099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endothelial dysfunction and inflammation: what is the link?
    Galle J; Quaschning T; Seibold S; Wanner C
    Kidney Int Suppl; 2003 May; (84):S45-9. PubMed ID: 12694307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tipping the redox balance of oxidative stress in fibrogenic pathways in chronic kidney disease.
    Okamura DM; Himmelfarb J
    Pediatr Nephrol; 2009 Dec; 24(12):2309-19. PubMed ID: 19421784
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oxidative Stress and Cardiovascular Complications in Chronic Kidney Disease, the Impact of Anaemia.
    Nuhu F; Bhandari S
    Pharmaceuticals (Basel); 2018 Oct; 11(4):. PubMed ID: 30314359
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factors and metabolic mechanisms in the pathogenesis of uraemic cardiac disease.
    Bhandari S
    Front Biosci (Landmark Ed); 2011 Jan; 16(4):1364-87. PubMed ID: 21196237
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Why do young people with chronic kidney disease die early?
    Kumar S; Bogle R; Banerjee D
    World J Nephrol; 2014 Nov; 3(4):143-55. PubMed ID: 25374808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Animal Models to Study Links between Cardiovascular Disease and Renal Failure and Their Relevance to Human Pathology.
    Hewitson TD; Holt SG; Smith ER
    Front Immunol; 2015; 6():465. PubMed ID: 26441970
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oxidative stress, anti-oxidant therapies and chronic kidney disease.
    Small DM; Coombes JS; Bennett N; Johnson DW; Gobe GC
    Nephrology (Carlton); 2012 May; 17(4):311-21. PubMed ID: 22288610
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oxidative stress in chronic kidney disease.
    Modaresi A; Nafar M; Sahraei Z
    Iran J Kidney Dis; 2015 May; 9(3):165-79. PubMed ID: 25957419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.